4Malinchoc M, Kamath PS, Gordon FD,et al. A model to predict poor sur- vival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000,31 ( 4 ) : 864-871.
7Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survivalin patients with end-stage liver disease[J]. Hepatology,2001,33 (2) :464-470.
8Cescon M, Cucchetti A, Grazi GL, et al. Indication of the extent of hepate- ctomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based onpreoperative variables[J]. Arch Surg, 2009,144 (1) :57-63.
9Greco E, Nanji S, Bromberg IL, et al. Predictors of peri-opertative morbi- dity and liver dysfunction after hepatic resection in patients with chronic liver disease[J]. HPB (Oxford), 2011,13 (8) : 559-565.
10Ren Z ,Xu Y ,Zhu S. Indocyanine green retention test avoiding liver failure after hepatectomy for hepatolithiasis[J]. Hepatogastroenterology, 2012,59 ( 115 ) : 782-784.
7Schiano TD,Bodian C,Schwartz ME,Glajchen N,Min AD.Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation.Transplantation 2000;69:545-550.
8Shi rabe K,Shimada M,Gion T,Hasegawa H,Takenaka K,Utsunomiya T,Sugimachi K.Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.J Am Coll Surg 1999;188:304-309.
10Gruttadauria S,Vasta F,Minervini MI,Piazza T,Arcadipane A,Marcos A,Gridelli B.Significance of the effective remnant liver volume in major hepatectomies.Am Surg 2005;71:235-240.
5Qinghua Meng,Zhengqiang Yang,Zhenyu Zhu,Juan Li,Xinyu Bi,Xiao Chen,Chunyi Hao,Zhen Huang,Fei Li,Xiao Li,Guangming Li,Yinmo Yang,Yefan Zhang,Haitao Zhao,Hong Zhao,Xu Zhu,Jiye Zhu,Jianqiang Cai,The Liver Tumor Branch of the China International Exchange and Promotive Association for Medical and Healthcare(CPAM),The Gastrointestinal Cancer Multidisciplinary Cooperation Group of Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,The Liver Cancer Professional Committee of Chinese Medical Doctor Association.Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer(2022 edition)[J].Chinese Medical Journal,2023,136(24):2909-2911.
